Advertisement

Incidence and Prevalence of Heart Failure in Adults with Congenital Heart Disease

  • Gerhard-Paul Diller
Chapter
Part of the Congenital Heart Disease in Adolescents and Adults book series (CHDAA)

Abstract

Heart failure (HF) is common in ACHD with a life prevalence of >30% in patients with complex lesions. It represents one of the two leading causes of death in this population and continues to increase as patients age. Patients with functionally univentricular hearts, systemic right ventricle, and tetralogy of Fallot are at highest risk of developing HF. With more patients with complex heart disease surviving to older age, HF is likely to become epidemic in this population. This chapter focuses on epidemiology of HF in ACHD patients, highlighting subgroups of patients at particular risk of HF, and attempts to prognosticate future changes in the prevalence of the condition.

Keywords

Incidence Prevalence Epidemiology Hospitalization Mortality 

References

  1. 1.
    Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–72.CrossRefPubMedGoogle Scholar
  2. 2.
    Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Poole-Wilson PA, Buller NP. Causes of symptoms in chronic congestive heart failure and implications for treatment. Am J Cardiol. 1988;62(2):31A–4A.CrossRefPubMedGoogle Scholar
  4. 4.
    Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46(6):e1–82.CrossRefPubMedGoogle Scholar
  5. 5.
    Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10(10):933–89.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292.CrossRefPubMedGoogle Scholar
  7. 7.
    Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A–13A.CrossRefPubMedGoogle Scholar
  8. 8.
    Christiansen MN, Kober L, Weeke P, Vasan RS, Jeppesen JL, Smith JG, et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation. 2017;135(13):1214–23.CrossRefPubMedGoogle Scholar
  9. 9.
    Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105(10):1189–94.CrossRefPubMedGoogle Scholar
  10. 10.
    Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106(1):92–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Sharma R, Bolger AP, Li W, Davlouros PA, Volk HD, Poole-Wilson PA, et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol. 2003;92(2):188–93.CrossRefPubMedGoogle Scholar
  12. 12.
    Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a Large Tertiary Centre. Circulation. 2015;132(22):2118–25.CrossRefPubMedGoogle Scholar
  13. 13.
    Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol. 2007;50(13):1263–71.CrossRefGoogle Scholar
  14. 14.
    Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000;86(10):1111–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Engelings CC, Helm PC, Abdul-Khaliq H, Asfour B, Bauer UM, Baumgartner H, et al. Cause of death in adults with congenital heart disease—an analysis of the German National Register for congenital heart defects. Int J Cardiol. 2016;211:31–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97(8):1238–43.CrossRefPubMedGoogle Scholar
  18. 18.
    Rodriguez FH III, Moodie DS, Parekh DR, Franklin WJ, Morales DL, Zafar F, et al. Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8(6):513–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Zomer AC, Vaartjes I, van der Velde ET, de Jong HM, Konings TC, Wagenaar LJ, et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol. 2013;168(3):2487–93.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of MünsterMünsterGermany
  2. 2.Imperial College of Science and MedicineLondonUK

Personalised recommendations